Can a leukemia drug be paused? trial tests break from Long-Term treatment

NCT ID NCT04963946

Ongoing Disease control Sponsor: French Innovative Leukemia Organisation Source: ClinicalTrials.gov ↗

Summary

This study is testing whether it's safe and effective to stop taking the drug acalabrutinib after 18 months for older adults with a type of blood cancer called chronic lymphocytic leukemia (CLL). The goal is to see if taking a break from the drug reduces long-term side effects and the risk of the cancer becoming resistant, while still controlling the disease. After the initial 18 months, some participants will continue the drug, while others will stop and only restart it if their cancer symptoms return.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

ARGENTEUIL - Centre hospitalier Victor Dupouy

Argenteuil, France
BOBIGNY - Hôpital Avicenne

Bobigny, France
Bordeaux Pessac

Pessac, 33604, France
CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique

Perpignan, 66000, France
CERGY-PONTOISE - Centre Hospitalier René Dubos

Pontoise, France
CHR ORLEANS - Hématologie

Orléans, 44100, France
CHU Estaing - Hématologie Clinique Adulte

Clermont-Ferrand, 63000, France
CHU Grenoble - Hématologie

Grenoble, 388043, France
CHU Nancy Brabois

Vandœuvre-lès-Nancy, 54500, France
CHU Pontchaillou - Hématologie Clinique BMT-HC

Rennes, 35033, France
Centre Henri Becquerel - Service Hématologie Clinique

Rouen, 76038, France
Centre Hospitalier Lyon Sud

Pierre-Bénite, 69495, France
Centre Hospitalier Regional Metz Thionville

Metz, 57085, France
Centre Hospitalier du Mans

Le Mans, 72000, France
Centre Léon Bérard - Hématologie

Lyon, 69373, France
Ch Avignon

Avignon, 84000, France
Ch Cote Basque

Bayonne, 64109, France
Chu Angers

Angers, 49933, France
Chu Reims

Reims, 51092, France
Corbeil-Essonnes -

Corbeil-Essonnes, France
Hopital E.Muller

Mulhouse, 68100, France
Hopital Pitie Salpetriere Service Hematologie Clinique - Pavillon de L'Enfant Et Adolescent

Paris, 75651, France
Hôpital Bretonneau - Hématologie et Thérapie Cellulaire

Tours, 37044, France
Hôpital Privé Sévigné

Cesson-Sévigné, 35510, France
Hôpital Saint Vincent de Paul

Lille, 59000, France
Hôpital Saint-Eloi - Hématologie Clinique

Montpellier, 34295, France
Hôpital de la Milétrie - Hématologie et Thérapie Cellulaire

Poitiers, 86021, France
IUCT ONCOPOLE - Hématologie

Toulouse, 31059, France
Institut Paoli-Calmettes - Hématologie Clinique

Marseille, 13273, France
Institut de Cancérologie Lucien Neuwirth

Saint-Priest-en-Jarez, 42271, France
VERSAILLES - Hôpital André Mignot

Versailles, France
Vannes - Chba

Vannes, France

Conditions

Explore the condition pages connected to this study.

UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA